Journal of Clinical Respiratory Medicine

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Opinion Article - Journal of Clinical Respiratory Medicine (2022) Volume 6, Issue 4

Treatments with heart failure with sleep disordered ventilation.

The majority of patients require positive airway pressure therapy to increase the intraluminal pressure in order to balance upper airway blockage. Numerous investigations have shown that PAP may stop the remodelling of the cardiac structure. Observational studies have demonstrated that CPAP increases survival. The goal of OSA treatment is to get rid of the underlying risk factors, like fat or fluid buildup, that make the disorder more likely to arise. Due to their high prevalence and negative effects on outcomes, breathing disruptions during sleep play a key role in patients with heart disorders. Obstructive sleep apnea, which is linked to atrial fibrillation and is a significant risk factor for arterial hypertension. Most people with heart failure have central sleep apnea or OSA, both of which are linked to poor prognoses. Continuous positive airway pressure has been shown to improve severe OSA symptoms and outcomes. The mainstays of heart failure patients care continue to be electrotherapy for brady arrhythmia or tachyarrhythmia, interventional treatment for coronary or valvular disorders, and pharmacological medications in accordance with current recommendations. After maximising conventional alternatives, patients with that is still present could need additional therapy. There aren't enough randomised controlled trials with a big sample size that demonstrate a survival benefit in these individuals receiving positive airway pressure treatment. Author(s): Lucas Oliver

Abstract Full Text PDF

Get the App